Host genetic determinants of human immunodeficiency virus infection and disease progression in children

Pediatric Research

Volumn 65, Issue SUPPL. 5, 2009, Pages

  Singh, Kumud K ^a   Spector, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN E; CD209 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NEVIRAPINE; RANTES; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; DISEASE COURSE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITY; HLA SYSTEM; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; INFLAMMATORY CELL; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VERTICAL TRANSMISSION; VIRUS INFECTIVITY; VIRUS LOAD;

CHEMOKINE CX3CL1; CHILD; DISEASE PROGRESSION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; PREGNANCY; RECEPTORS, CCR5;

EID: 68049118309     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31819dca03     Document Type: Review

References (83)

1. Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Riviere Y 1998 Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age. J Infect Dis 178:1019-1023 (Pubitemid 28452193)
2. Misrahi M, Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Delfraissy JF, Blanche S 1998 CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA 279:277-280 (Pubitemid 28071017)
3. Shearer WT, Kalish LA, Zimmerman PA 1998 CCR5 HIV-1 vertical transmission. Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 17:180-181
4. Barroga CF, Raskino C, Fangon MC, Palumbo PE, Baker CJ, Englund JA, Spector SA 2000 The CCR5 Delta 32 allele slows disease progression of human immunodeficiency virus (HIV)-1 infected children receiving antiretroviral treatment. J Infect Dis 182:413-419 (Pubitemid 30654822)
5. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ 1996 Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862 (Pubitemid 26322495)
6. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, Macdonald ME, Stuhlmann H, Koup RA, Landau NR 1996 Homozygous defect in Hiv-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377 (Pubitemid 26272077)
7. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M 1996 Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725 (Pubitemid 26282179)
8. Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, Karanicolas R, Deutsch L, Huang Y, Lew JF, McIntosh K, Pollack H, Borkowsky W, Spiegel HM, Palumbo P, Oleske J, Bardeguez A, Luzuriaga K, Sullivan J, Wolinsky SM, Koup RA, Ho DD, Moore JP 1999 A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 73:10264-10271
9. Kostrikis LG, Huang YX, Moore JP, Wolinsky SM, Zhang LQ, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD 1998 A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4:350-353 (Pubitemid 28144097)
10. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M 1998 Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911
11. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ 1997 Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City cohort (SFCC), ALIVE Study. Science 277:959-965 (Pubitemid 27366682)
12. Winkler C, Modi W, Smith MW, Nelson GW, Wu XY, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, Obrien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, Obrien SJ 1998 Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279:389-393 (Pubitemid 28063375)
13. Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR 2001 Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 135:782-795
14. Meyer L, Magierowska M, Hubert JB, Theodorou I, van Rij R, Prins M, de Roda Husman AM, Coutinho R, Schuitemaker H 1999 CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS. AIDS 13:624-626
15. van Rij RP, Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H 1998 Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 178:1806-1811 (Pubitemid 28558160)
16. John GC, Rousseau C, Dong T, Rowland-Jones S, Nduati R, Mbori-Ngacha D, Rostron T, Kreiss JK, Richardson BA, Overbaugh J 2000 Maternal SDF1 3′A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission. J Virol 74:5736-5739 (Pubitemid 30346611)
17. Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE, Spector SA 2003 Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis 188:1461-1472 (Pubitemid 37523931)
18. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD 1993 A cross-sectional comparison of persons with syncytium-inducing and non-syncytium-inducing human immunodeficiency virus. J Infect Dis 168:1374-1379 (Pubitemid 23344894)
19. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M 1992 Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354-1360
20. Spencer LT, Ogino MT, Dankner WM, Spector SA 1994 Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J Infect Dis 169:491-495 (Pubitemid 24062988)
21. Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F 1988 Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62:2026-2032 (Pubitemid 18148930)
22. Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ 2001 Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection. AIDS 15:1343-1352 (Pubitemid 32662286)
23. Tresoldi E, Romiti ML, Boniotto M, Crovella S, Salvatori F, Palomba E, Pastore A, Cancrini C, de Martino M, Plebani A, Castelli G, Rossi P, Tovo PA, Amoroso A, Scarlatti G 2002 Prognostic value of the stromal cell-derived factor 1 3′A mutation in pediatric human immunodeficiency virus type 1 infection. J Infect Dis 185:696-700 (Pubitemid 34171477)
24. Singh KK, Hughes MD, Chen J, Spector SA 2005 Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load. J Infect Dis 191:1971-1980 (Pubitemid 40705406)
25. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O 1997 Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-530 (Pubitemid 27508241)
26. Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM 1998 Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 273:23799-23804 (Pubitemid 28435714)
27. Meucci O, Fatatis A, Simen AA, Miller RJ 2000 Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97:8075-8080 (Pubitemid 30460775)
28. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debré P, Théodorou I, Combadière C 2000 Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287:2274-2277 (Pubitemid 30177034)
29. Faure S, Meyer L, Genin E, Pellet P, Debre P, Theodorou I, Combadiere C 2003 Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression. J Acquir Immune Defic Syndr 32:335-337 (Pubitemid 36331707)
30. Brumme ZL, Dong WW, Chan KJ, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR 2003 Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response. AIDS 17:201-208
31. Foussat A, Bouchet-Delbos L, Berrebi D, Durand-Gasselin I, Coulomb-L'Hermine A, Krzysiek R, Galanaud P, Levy Y, Emilie D 2001 Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood 98:1678-1686
32. Cotter R, Williams C, Ryan L, Erichsen D, Lopez A, Peng H, Zheng J 2002 Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J Neurovirol 8:585-598 (Pubitemid 36104722)
33. Pereira CF, Middel J, Jansen G, Verhoef J, Nottet HS 2001 Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol 115:168-175 (Pubitemid 32245665)
34. van der Meer P, Ulrich AM, Gonzalez-Scarano F, Lavi E 2000 Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 69:192-201 (Pubitemid 32007068)
35. Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU 2002 Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69:418-426 (Pubitemid 34809490)
36. Ometto L, Zanchetta M, Mainardi M, De Salvo GL, Garcia-Rodriguez MC, Gray L, Newell ML, Chieco-Bianchi L, De Rossi A 2000 Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS 14:1721-1729 (Pubitemid 30695229)
37. Behbahani H, Popek E, Garcia P, Andersson J, Spetz AL, Landay A, Flener Z, Patterson BK 2000 Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am J Pathol 157:1811-1818
38. Ank N, Petersen K, Malmgaard L, Mogensen SC, Paludan SR 2005 Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2. J Virol 79:9831-9841 (Pubitemid 41022325)
39. Martinson JJ, Hong L, Karanicolas R, Moore JP, Kostrikis LG 2000 Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype. AIDS 14:483-489 (Pubitemid 30209690)
40. Semba RD, Miotti PG, Chiphangwi JD, Dallabetta G, Yang LP, Saah A, Hoover D 1998 Maternal vitamin A deficiency and infant mortality in Malawi. J Trop Pediatr 44:232-234 (Pubitemid 28379891)
41. Coutsoudis A, Pillay K, Kuhn L, Spooner E, Tsai WY, Coovadia HM 2001 Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS 15:379-387 (Pubitemid 32163824)
42. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM 1999 Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study group. AIDS 13:1517-1524
43. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB 1999 Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354:795-802
44. Singh KK, Hughes MD, Chen J, Phiri K, Rousseau C, Kuhn L, Coutsoudis A, Jackson JB, Guay LA, Musoke P, Mmiro F, Semba RD, Spector SA 2008 Associations of chemokine receptor polymorphisms with HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by Antiretrovirals. J Acquir Immune Defic Syndr 49:259-265
45. Salkowitz JR, Bruse SE, Meyerson H, Valdez H, Mosier DE, Harding CV, Zimmerman PA, Lederman MM 2003 CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro. Clin Immunol 108:234-240 (Pubitemid 37117369)
46. Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, Gray GE, Tiemessen CT 2007 African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS 21:1753-1761 (Pubitemid 47237563)
47. Schramm DB, Kuhn L, Gray GE, Tiemessen CT 2006 In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr 42:545-553
48. Pedersen BR, Kamwendo D, Blood M, Mwapasa V, Molyneux M, North K, Rogerson SJ, Zimmerman P, Meshnick SR 2007 CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLoS One 2:e838
49. John GC, Bird T, Overbaugh J, Nduati R, Mbori-Ngacha D, Rostron T, Dong T, Kostrikis L, Richardson B, Rowland-Jones SL 2001 CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. J Infect Dis 184:89-92 (Pubitemid 32568505)
50. Mangano A, Prada F, Roldan A, Picchio G, Bologna R, Sen L 1998 Distribution of CCR-5 delta32 allele in Argentinean children at risk of HIV-1 infection: its role in vertical transmission. AIDS 12:109-110 (Pubitemid 28021321)
51. Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Blanche S, Delfraissy JF, Misrahi M 1999 CCR2B-64I chemokine receptor allele and mother-to-child HIV-1 transmission or disease progression in children. French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr 22:267-271
52. Brouwer KC, Yang C, Parekh S, Mirel LB, Shi YP, Otieno J, Lal AA, Lal RB 2005 Effect of CCR2 chemokine receptor polymorphism on HIV type 1 mother-to-child transmission and child survival in Western Kenya. AIDS Res Hum Retroviruses 21:358-362 (Pubitemid 40800451)
53. Modi WS 2004 CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12. Genomics 83:735-738
54. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'Connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK 2005 The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307:1434-1440 (Pubitemid 40321934)
55. Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, Gray GE, Kuhn L, Tiemessen CT 2006 Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 87:2055-2065 (Pubitemid 43985890)
56. Dommett RM, Klein N, Turner MW 2006 Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68:193-209 (Pubitemid 44341793)
57. Garred P, Larsen F, Madsen HO, Koch C 2003 Mannose-binding lectin deficiency-revisited. Mol Immunol 40:73-84
58. Kilpatrick DC 2002 Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 1572:401-413
59. Turner MW 1998 Mannose-binding lectin (MBL) in health and disease. Immunobiology 199:327-339
60. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U, Reid KB, Jensenius JC 1997 A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510 (Pubitemid 27164078)
61. Singh KK, Lieser A, Ruan PK, Fenton T, Spector SA 2008 An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children. J Allergy Clin Immunol 122:173-180, 180.e171-172 (Pubitemid 351899081)
62. Boniotto M, Crovella S, Pirulli D, Scarlatti G, Spano A, Vatta L, Zezlina S, Tovo PA, Palomba E, Amoroso A 2000 Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 1:346-348
63. Dzwonek A, Novelli V, Bajaj-Elliott M, Turner M, Clapson M, Klein N 2006 Mannose-binding lectin in susceptibility and progression of HIV-1 infection in children. Antivir Ther 11:499-505 (Pubitemid 44024858)
64. Garred P, Madsen HO, Balslev U, Hofmann B, Pedersen C, Gerstoft J, Svejgaard A 1997 Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349:236-240 (Pubitemid 27050989)
65. Faber J, Schuessler T, Finn A, Murdoch C, Zenz W, Habermehl P, Meyer CU, Zabel BU, Schmitt H, Zepp F, Knuf M 2007 Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood. Pediatr Infect Dis J 26:243-246 (Pubitemid 46340772)
66. Koch A, Melbye M, Sorensen P, Homoe P, Madsen HO, Molbak K, Hansen CH, Andersen LH, Hahn GW, Garred P 2001 Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316-1321 (Pubitemid 32216146)
67. O'Brien SJ, Gao X, Carrington M 2001 HLA and AIDS: a cautionary tale. Trends Mol Med 7:379-381
68. Carrington M, O'Brien SJ 2003 The influence of HLA genotype on AIDS. Annu Rev Med 54:535-551
69. Mackelprang RD, John-Stewart G, Carrington M, Richardson B, Rowland-Jones S, Gao X, Mbori-Ngacha D, Mabuka J, Lohman-Payne B, Farquhar C 2008 Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis 197:1156-1161 (Pubitemid 351590051)
70. Polycarpou A, Ntais C, Korber BT, Elrich HA, Winchester R, Krogstad P, Wolinsky S, Rostron T, Rowland-Jones SL, Ammann AJ, Ioannidis JP 2002 Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses 18:741-746 (Pubitemid 34936851)
71. Kuhn L, Abrams EJ, Palumbo P, Bulterys M, Aga R, Louie L, Hodge T 2004 Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression. AIDS 18:1281-1289 (Pubitemid 38822706)
72. Simon JH, Gaddis NC, Fouchier RA, Malim MH 1998 Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 4:1397-1400
73. Sheehy AM, Gaddis NC, Malim MH 2003 The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407 (Pubitemid 37466190)
74. An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, Winkler CA 2004 APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 78:11070-11076
75. Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, Delfraissy JF, Debre P, McIlroy D, Theodorou I, Shioda T 2002 Protective effect of interleukin- 4-589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Infect Dis 185:1183-1186 (Pubitemid 34297779)
76. Singh KK, Hughes MD, Chen J, Spector SA 2004 Lack of protective effects of Interleukin-4-589-C/T polymorphism against HIV-1-related disease progression and central nervous system impairment, in children. J Infect Dis 189:587-592 (Pubitemid 38270910)
77. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK 2002 HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 99:13795-13800 (Pubitemid 35215460)
78. Singh KK, Hughes MD, Chen J, Spector SA 2006 Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the United States. AIDS 20:475-478
79. Saitoh A, Sarles E, Capparelli E, Aweeka F, Kovacs A, Burchett SK, Wiznia A, Nachman S, Fenton T, Spector SA 2007 CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. AIDS 21:2191-2199
80. Saitoh A, Singh KK, Powell CA, Fenton T, Fletcher CV, Brundage R, Starr S, Spector SA 2005 An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children. AIDS 19:371-380 (Pubitemid 40446183)
81. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jagel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A 2008 HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568-579
82. Blanche S 1994 HIV in infants and children: transmission and progression. In: HIV: Advances in Research and Therapy. Cliggot Communications Greenwich, Connecticut, 4, pp 9-13
83. Spector SA 2001 Mother-to-infant transmission of HIV-1: the placenta fights back. J Clin Invest 107:267-269